DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $262,051 | +162.1% | 8,391 | +345.1% | 0.00% | – |
Q1 2021 | $100,000 | -86.7% | 1,885 | -80.8% | 0.00% | – |
Q4 2020 | $754,000 | +579.3% | 9,836 | +229.4% | 0.00% | – |
Q3 2020 | $111,000 | -17.8% | 2,986 | -40.6% | 0.00% | – |
Q2 2020 | $135,000 | +1587.5% | 5,031 | +956.9% | 0.00% | – |
Q1 2020 | $8,000 | -92.4% | 476 | -92.1% | 0.00% | – |
Q4 2019 | $105,000 | +43.8% | 6,023 | +25.4% | 0.00% | – |
Q3 2019 | $73,000 | -12.0% | 4,802 | +20.4% | 0.00% | – |
Q2 2019 | $83,000 | +538.5% | 3,990 | +515.7% | 0.00% | – |
Q4 2018 | $13,000 | +85.7% | 648 | +105.7% | 0.00% | – |
Q3 2018 | $7,000 | +250.0% | 315 | +162.5% | 0.00% | – |
Q2 2018 | $2,000 | – | 120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |